Supplemental Cash Flow Disclosures (Tables)

12 Months Ended

Dec. 31, 2021

Supplemental Cash Flow Disclosure [Abstract]

Summary of Changes in Non-cash Working Capital

	Year ended December 31
	2021			2020			2019
Cash provided by (used in):
Accounts receivable		7,328			(2,037	)		(19,625	)
Biological assets		3,829			13,789			19,328
Inventory		(18,318	)		(12,315	)		(57,977	)
Prepaid expenses and deposits		(3,922	)		2,280			(7,213	)
Investments		(402	)		—			—
Property, plant and equipment		22			—			—
Accounts payable and accrued liabilities		9,665			(20,793	)		27,819
Convertible notes		—			—			(152	)
		(1,798	)		(19,076	)		(37,820	)
Changes in non-cash working capital relating to:
Operating		(1,534	)		(5,259	)		(41,626	)
Investing		(612	)		(11,319	)		1,659
Financing		348			(2,498	)		2,147
		(1,798	)		(19,076	)		(37,820	)
Cash interest paid		—			6,094			13,753